{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:59:17Z","timestamp":1785473957425,"version":"3.56.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Mycobacterium abscessus<\/jats:italic>\n                      is an emerging rapidly growing nontuberculous mycobacterium that causes chronic skin and soft tissue infections, but its pathogenic potential remains difficult to assess in vivo because existing animal models do not fully recapitulate localized cutaneous infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We established a murine excisional wound infection model designed to mimic cutaneous barrier disruption and compared it with conventional subcutaneous inoculation. BALB\/c mice were infected with a rough-morphotype clinical isolate or rough-morphotype ATCC 19977, and lesion development, bacterial recovery, histopathology, local cytokine mRNA expression, and serum cytokine\/chemokine profiles were assessed at terminal time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with subcutaneous injection, the wound model generated persistent lesions with histopathological features consistent with pyogranulomatous inflammation, including foamy macrophages, multinucleated giant cells, fibroblast proliferation, and localized interferon-gamma (IFNgamma) expression. In the strains tested, the model revealed strain-dependent differences in infection establishment: the clinical isolate produced frequent chronic nodular lesions, whereas roughmorphotype ATCC 19977 showed lower lesion incidence under the same experimental conditions. Local tissue and serum cytokine profiling demonstrated a T helper 1 (Th1)-skewed immune response detectable at both terminal time points, associated with bacterial recovery from infected tissues and detectable splenic bacterial recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      These findings suggest that the excisional wound model provides a clinically relevant platform for studying localized cutaneous\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      infection. Further validation using additional clinical isolates and mechanistic studies will be required to define its broader applicability.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1828052","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:24:24Z","timestamp":1785471864000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathophysiological and immunological characterization of a murine excisional wound infection model for cutaneous Mycobacterium abscessus infection"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuri","family":"Jung","sequence":"first","affiliation":[{"name":"Animal Research and Operation Laboratory, Institut Pasteur Korea","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Wood","sequence":"additional","affiliation":[{"name":"Antibacterial Resistance Laboratory, Institut Pasteur Korea","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong-Yub","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Seoul National University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakwon","family":"Kwak","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Seoul National University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Hospital","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Joon","family":"Yim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Seoul National University College of Medicine","place":["Seoul, Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyeon","family":"Yang","sequence":"additional","affiliation":[{"name":"Animal Research and Operation Laboratory, Institut Pasteur Korea","place":["Seongnam, Republic of Korea"]},{"name":"Department of Advanced Drug discovery & development, University of Science and Technology (UST)","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"10.1128\/microbiolspec.tbtb2","DOI":"10.1128\/microbiolspec.TBTB2-0029-2016","article-title":"Pathology of tuberculosis: how the pathology of human tuberculosis informs and directs animal models","volume":"5","author":"Basaraba","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"E943","DOI":"10.1073\/pnas.1321390111","article-title":"Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation","volume":"111","author":"Bernut","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838425","article-title":"Exploring macrophage-dependent wound regeneration during mycobacterial infection in zebrafish","volume":"13","author":"Bohaud","year":"2022","journal-title":"Front. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2008.12.032","article-title":"Who benefits from granulomas, mycobacteria or host","volume":"136","author":"Bold","year":"2009","journal-title":"Cell."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1128\/IAI.67.9.4700-4707.1999","article-title":"Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection","volume":"67","author":"Byrd","year":"1999","journal-title":"Infect. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/IAI.00835-06","article-title":"Hypervirulence of a rough variant of the Mycobacterium abscessus type strain","volume":"75","author":"Catherinot","year":"2007","journal-title":"Infect. Immun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.coi.2007.07.004","article-title":"Interleukin-12 and tuberculosis: an old story revisited","volume":"19","author":"Cooper","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"E10147","DOI":"10.1073\/pnas.1812984115","article-title":"MmpL8MAB controls Mycobacterium abscessus virulence and production of a previously unknown glycolipid family","volume":"115","author":"Dubois","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1099\/mic.0.28625-0","article-title":"Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype","volume":"152","author":"Howard","year":"2006","journal-title":"Microbiol. (Reading)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01347-17","article-title":"Mycobacterium abscessus whiB7 regulates a species-specific repertoire of genes to confer extreme antibiotic resistance","volume":"61","author":"Hurst-Hess","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/icb.2011.72","article-title":"Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62\/SQSTM1","volume":"90","author":"Lee","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1346-8138.2010.00960.x","article-title":"Non-tuberculous mycobacterial infections of the skin: a retrospective study of 29 cases","volume":"37","author":"Lee","year":"2010","journal-title":"J. Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","article-title":"IL-17 production is dominated by \u03b3\u03b4 T cells rather than CD4 T cells during Mycobacterium tuberculosis infection","volume":"177","author":"Lockhart","year":"2006","journal-title":"J. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jsap.13386","article-title":"Histological and immunohistochemical features suggesting aetiological differences in lymph node and (muco)cutaneous feline tuberculosis lesions","volume":"63","author":"Mitchell","year":"2022","journal-title":"J. Small Anim. Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1128\/AAC.00459-15","article-title":"Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models","volume":"59","author":"Obreg\u00f3n-Henao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung","volume":"184","author":"Okamoto Yoshida","year":"2010","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1189\/jlb.1007696","article-title":"Animal model of Mycobacterium abscessus lung infection","volume":"83","author":"Ordway","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052310","article-title":"A BALB\/c mouse model of Mycobacterium abscessus lung infection based on once-weekly cyclophosphamide administration","volume":"18","author":"Rimal","year":"2025","journal-title":"Dis. Model. Mech."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/archderm.142.10.1287","article-title":"Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility","volume":"142","author":"Uslan","year":"2006","journal-title":"Arch. Dermatol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1828052\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:24:25Z","timestamp":1785471865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1828052\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":22,"alternative-id":["10.3389\/fcimb.2026.1828052"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1828052","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"1828052"}}